Eligibility criteria
Condition
Major Depressive Disorder
Sex
Females and Males
Age
18-75 years
Inclusion criteria
Show details
- Subjects must have a primary diagnosis of major depressive disorder (MDD)
- Depressive symptoms for at least 30 days prior to the screening visit
- Minimum screening and study day -1 (baseline) scores of 20 on the Hamilton Psychiatric
Rating Scale for Depression (HAM D17)
Exclusion criteria
Show details
- Treatment with DVS-233 SR at any time in the past
- Treatment with venlafaxine (immediate release [IR] or extended release [ER]) within 90
days of study day 1
- Known hypersensitivity to venlafaxine (IR or ER)